A novel effect of geraniin on OPG/RANKL signaling in osteoblasts
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
DOI: | 10.1590/s2175-97902018000317567 |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/153857 |
Resumo: | In this study, the effects of geraniin on osteoprotegerin/receptor activator of nuclear factor-κB ligand(OPG/ RANKL) in regulating the proliferation of osteoblasts and suppression of osteoclast-like cells (OLC) in OLC-osteoblast co-cultured system in vitro were investigated. Osteoblasts were cultured and identified with alkaline phosphatase (ALP), gomori stain, and mineralized nodule stain. OLCs were isolated from long bones of Sprague–Dawley (SD) rats and identified with tartrate-resistant acid phosphatase(TRAP) stain. Methyl thiazolyl tetrazolium assay was used to examine the proliferation of osteoblasts, and immunocytochemistry and in situ hybridization to analyze the expression OPG/RANKL in osteoblasts co-cultured with osteoclasts under the action of geraniin, respectively. Geraniin could regulate the proliferation of osteoblasts MC3T3-E1, decrease the number of OLC in OLC-osteoblast co-cultured system, and inhibit the bone resorption areas and resorption pits of OLC in vitro experiments. Geraniin could promote the mRNA and protein expression levels of OPG and suppress those of RANKL in osteoblasts. These results indicate that geraniin has a promoting effect on the proliferation of osteoblasts and an inhibitory effect on the osteoclastic bone-resorption through regulating OPG/RANKL signaling pathway in OLC-OB co-cultured system. |
id |
USP-31_4250e6c91177d90b66178da16d2fbffd |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/153857 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
spelling |
A novel effect of geraniin on OPG/RANKL signaling in osteoblastsGeraniin/effectOsteoblastsOsteoprotegerinReceptor activator of nuclear factor -κ B ligandIn this study, the effects of geraniin on osteoprotegerin/receptor activator of nuclear factor-κB ligand(OPG/ RANKL) in regulating the proliferation of osteoblasts and suppression of osteoclast-like cells (OLC) in OLC-osteoblast co-cultured system in vitro were investigated. Osteoblasts were cultured and identified with alkaline phosphatase (ALP), gomori stain, and mineralized nodule stain. OLCs were isolated from long bones of Sprague–Dawley (SD) rats and identified with tartrate-resistant acid phosphatase(TRAP) stain. Methyl thiazolyl tetrazolium assay was used to examine the proliferation of osteoblasts, and immunocytochemistry and in situ hybridization to analyze the expression OPG/RANKL in osteoblasts co-cultured with osteoclasts under the action of geraniin, respectively. Geraniin could regulate the proliferation of osteoblasts MC3T3-E1, decrease the number of OLC in OLC-osteoblast co-cultured system, and inhibit the bone resorption areas and resorption pits of OLC in vitro experiments. Geraniin could promote the mRNA and protein expression levels of OPG and suppress those of RANKL in osteoblasts. These results indicate that geraniin has a promoting effect on the proliferation of osteoblasts and an inhibitory effect on the osteoclastic bone-resorption through regulating OPG/RANKL signaling pathway in OLC-OB co-cultured system.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2018-11-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/15385710.1590/s2175-97902018000317567Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 3 (2018); e17567Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 3 (2018); e17567Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 3 (2018); e175672175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/153857/150215Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)info:eu-repo/semantics/openAccessZhang, XiaochaoYang, RenhuaLong, JiangHe, BoZhang, YueFu, TingShen, ZhiqiangChen, Peng2019-03-17T13:04:01Zoai:revistas.usp.br:article/153857Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2019-03-17T13:04:01Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
A novel effect of geraniin on OPG/RANKL signaling in osteoblasts |
title |
A novel effect of geraniin on OPG/RANKL signaling in osteoblasts |
spellingShingle |
A novel effect of geraniin on OPG/RANKL signaling in osteoblasts A novel effect of geraniin on OPG/RANKL signaling in osteoblasts Zhang, Xiaochao Geraniin/effect Osteoblasts Osteoprotegerin Receptor activator of nuclear factor -κ B ligand Zhang, Xiaochao Geraniin/effect Osteoblasts Osteoprotegerin Receptor activator of nuclear factor -κ B ligand |
title_short |
A novel effect of geraniin on OPG/RANKL signaling in osteoblasts |
title_full |
A novel effect of geraniin on OPG/RANKL signaling in osteoblasts |
title_fullStr |
A novel effect of geraniin on OPG/RANKL signaling in osteoblasts A novel effect of geraniin on OPG/RANKL signaling in osteoblasts |
title_full_unstemmed |
A novel effect of geraniin on OPG/RANKL signaling in osteoblasts A novel effect of geraniin on OPG/RANKL signaling in osteoblasts |
title_sort |
A novel effect of geraniin on OPG/RANKL signaling in osteoblasts |
author |
Zhang, Xiaochao |
author_facet |
Zhang, Xiaochao Zhang, Xiaochao Yang, Renhua Long, Jiang He, Bo Zhang, Yue Fu, Ting Shen, Zhiqiang Chen, Peng Yang, Renhua Long, Jiang He, Bo Zhang, Yue Fu, Ting Shen, Zhiqiang Chen, Peng |
author_role |
author |
author2 |
Yang, Renhua Long, Jiang He, Bo Zhang, Yue Fu, Ting Shen, Zhiqiang Chen, Peng |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Zhang, Xiaochao Yang, Renhua Long, Jiang He, Bo Zhang, Yue Fu, Ting Shen, Zhiqiang Chen, Peng |
dc.subject.por.fl_str_mv |
Geraniin/effect Osteoblasts Osteoprotegerin Receptor activator of nuclear factor -κ B ligand |
topic |
Geraniin/effect Osteoblasts Osteoprotegerin Receptor activator of nuclear factor -κ B ligand |
description |
In this study, the effects of geraniin on osteoprotegerin/receptor activator of nuclear factor-κB ligand(OPG/ RANKL) in regulating the proliferation of osteoblasts and suppression of osteoclast-like cells (OLC) in OLC-osteoblast co-cultured system in vitro were investigated. Osteoblasts were cultured and identified with alkaline phosphatase (ALP), gomori stain, and mineralized nodule stain. OLCs were isolated from long bones of Sprague–Dawley (SD) rats and identified with tartrate-resistant acid phosphatase(TRAP) stain. Methyl thiazolyl tetrazolium assay was used to examine the proliferation of osteoblasts, and immunocytochemistry and in situ hybridization to analyze the expression OPG/RANKL in osteoblasts co-cultured with osteoclasts under the action of geraniin, respectively. Geraniin could regulate the proliferation of osteoblasts MC3T3-E1, decrease the number of OLC in OLC-osteoblast co-cultured system, and inhibit the bone resorption areas and resorption pits of OLC in vitro experiments. Geraniin could promote the mRNA and protein expression levels of OPG and suppress those of RANKL in osteoblasts. These results indicate that geraniin has a promoting effect on the proliferation of osteoblasts and an inhibitory effect on the osteoclastic bone-resorption through regulating OPG/RANKL signaling pathway in OLC-OB co-cultured system. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-11-29 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/153857 10.1590/s2175-97902018000317567 |
url |
https://www.revistas.usp.br/bjps/article/view/153857 |
identifier_str_mv |
10.1590/s2175-97902018000317567 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/153857/150215 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso) info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso) |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 3 (2018); e17567 Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 3 (2018); e17567 Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 3 (2018); e17567 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1822179023013281792 |
dc.identifier.doi.none.fl_str_mv |
10.1590/s2175-97902018000317567 |